Wil2-S Cells
USD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | WIL2-S is a human B-lymphoblastoid cell line derived from peripheral blood lymphocytes and immortalized by Epstein-Barr virus (EBV) infection. It originates from a healthy adult donor and exhibits characteristics typical of EBV-transformed B cells, including suspension growth, expression of B-cell surface markers, and stable proliferation in standard lymphoid culture media. As a non-tumor-derived, EBV-immortalized lymphoblastoid line, WIL2-S is widely used as a reference model in immunology, genotoxicity, and DNA repair studies. WIL2-S has been extensively applied in cytogenetic and mutagenesis assays, particularly in micronucleus and chromosomal instability testing, due to its stable karyotype and well-characterized response to DNA-damaging agents. The cell line is proficient in DNA repair pathways and has served as a comparator in studies evaluating oxidative stress, radiation-induced damage, and chemotherapeutic genotoxicity. Its lymphoid origin and reproducible growth characteristics make it suitable for evaluating clastogenic and aneugenic effects in vitro under controlled experimental conditions. Because WIL2-S is not derived from a malignant tumor but rather represents an EBV-immortalized normal B-cell lineage, it provides an important baseline model for distinguishing cancer-specific molecular alterations from general lymphoid cellular responses. Researchers commonly use this cell line as a non-transformed reference in studies of genome stability, immune cell signaling, and mechanisms of cellular stress response. |
|---|---|
| Organism | Human |
| Tissue | Spleen |
| Disease | Hereditary spherocytosis |
| Synonyms | WIL2-S, WIL2/S, WIL2S, WIL2 Secreting |
Characteristics
| Age | 5 years |
|---|---|
| Gender | Male |
| Ethnicity | Caucasian |
| Morphology | lymphoblast |
| Cell type | B-cell |
| Growth properties | suspension |
Regulatory Data
| Citation | Wil2-S (Cytion catalog number 305905) |
|---|---|
| Biosafety level | 2 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_3809 |
Biomolecular Data
| Mutational profile | Mutation: p.Ser1163Ala, Homozygous |
|---|
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | None |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305905-221225 | Certificate of Analysis | 03. Feb. 2026 | 305905 |